Does CARFILZOMIB Cause Infusion site induration? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Infusion site induration have been filed in association with CARFILZOMIB (KYPROLIS). This represents 0.0% of all adverse event reports for CARFILZOMIB.
6
Reports of Infusion site induration with CARFILZOMIB
0.0%
of all CARFILZOMIB reports
0
Deaths
0
Hospitalizations
How Dangerous Is Infusion site induration From CARFILZOMIB?
Of the 6 reports.
Is Infusion site induration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CARFILZOMIB. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does CARFILZOMIB Cause?
Plasma cell myeloma (2,238)
Off label use (2,120)
Death (1,442)
Thrombocytopenia (1,265)
Fatigue (1,048)
Pneumonia (1,016)
Pyrexia (969)
Anaemia (910)
Dyspnoea (881)
Neutropenia (874)
What Other Drugs Cause Infusion site induration?
TREPROSTINIL (598)
HUMAN IMMUNOGLOBULIN G (209)
FOSCARBIDOPA\FOSLEVODOPA (112)
AMBRISENTAN (49)
MACITENTAN (26)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (25)
CAPECITABINE (23)
EVEROLIMUS (22)
ZOLEDRONIC ACID (22)
PAMIDRONATE (20)
Which CARFILZOMIB Alternatives Have Lower Infusion site induration Risk?
CARFILZOMIB vs CARGLUMIC ACID
CARFILZOMIB vs CARIPRAZINE
CARFILZOMIB vs CARISOPRODOL
CARFILZOMIB vs CARMUSTINE
CARFILZOMIB vs CARTEOLOL